COMPOSITIONS CONTAINING NAPHTHYRIDINE DERIVATIVES AND ALUMINUM-CONTAINING AUXILIARY AGENT, INTENDED FOR USE IN TREATMENT OF SOLID TUMORS Russian patent published in 2022 - IPC A61K31/675 A61K39/00 A61K45/06 A61K9/19 A61P35/00 

Abstract RU 2787157 C2

FIELD: pharmaceutics.

SUBSTANCE: invention relates to the field of pharmaceutics, namely to a pharmaceutical combination for the treatment of solid tumor, containing: a) effective amount of the first pharmaceutical compositions containing 3-(5-amino-2-(4-(2-(3,3-difluor-3-phosphonopropoxy)ethoxy)-2-methylphenethyl)benzo[f][1,7]naphthyridine-8-yl)propanoic acid or its pharmaceutically acceptable salt, aluminum-containing particles, a buffer agent, and one or several pharmaceutically acceptable auxiliary substances, where the buffer agent is tris-buffer; pharmaceutically acceptable auxiliary substance is mannitol; the composition has pH in the range from 6.5 to 9.0, and aluminum-containing particles are a suspension of aluminum hydroxide particles, and b) effective amount of the second pharmaceutical composition containing an antibody to PD-L1. The invention also relates to a pharmaceutical combination for the treatment of solid tumor, such as defined above, additionally containing c) effective amount of the third pharmaceutical composition containing an antibody to CTLA-4.

EFFECT: effective treatment of solid tumors.

7 cl, 10 dwg, 17 tbl, 15 ex

Similar patents RU2787157C2

Title Year Author Number
IL-10/FC FUSION PROTEINS SUITABLE AS IMMUNOTHERAPY ENHANCERS 2020
  • Go, Yujgan
  • Tan, Li
  • Se, Yuj-Tsin
RU2825306C1
NOVEL APPROACH TO CANCER TREATMENT USING IMMUNOMODULATION 2016
  • Mehta, Vimal D.
  • Rastelli, Luca
  • Sapra, Aparna Katoch
RU2817047C2
COMBINED TREATMENT METHODS USING ALK INHIBITORS 2015
  • Lebvol Devid
  • Peters Malte
  • Li Nansin
  • Lau I Yan
  • Skott Dzheffri
RU2718914C2
ANTIBODIES TO HUMAN INTERLEUKIN-2 AND THEIR APPLICATION 2018
  • Surh, Charles D.
  • Lee, Jun-Young
RU2745451C1
COMBINATION OF AN IMMUNE CHECKPOINT MODULATOR AND A COMPLEX CONTAINING A CELL-PENETRATING PEPTIDE, A CARGO MOLECULE, AND A TLR PEPTIDE AGONIST, FOR APPLICATION IN MEDICINE 2017
  • Derouazi Madiha
  • Belnoue Elodie
RU2769314C1
COMBINATION OF IMMUNE CHECKPOINT MODULATOR AND COMPLEX CONTAINING CELL-PENETRATING PEPTIDE, CARGO MOLECULE, AND TLR PEPTIDE AGONIST FOR MEDICAL USE 2017
  • Deruazi Madikha
  • Belnu Elodi
RU2748378C2
COMBINATION 2015
  • Lyne, Paul, Dermot
  • Mccoon, Patricia, Elizabeth
  • Woessner, Richard
RU2744841C2
COMBINATION THERAPY OF ANTIBODY TO PROGASTRIN AND IMMUNOTHERAPY FOR CANCER TREATMENT 2018
  • Prier, Aleksandr
RU2784604C2
USE OF ANTI-PD-1 ANTIBODY IN PREPARATION OF MEDICINAL AGENT FOR TREATING SOLID TUMOURS 2020
  • Feng Hui
  • Wu Hai
  • Yao Sheng
RU2825845C2
IMPROVED IMMUNE CELLS WITH DOUBLE shRNA AND COMPOSITIONS CONTAINING THEM 2019
  • Kim, Chan Hyuk
  • Lee, Young-Ho
  • Lee, Yujean
  • Lee, Hyeongji
  • Lee, Sang Hoon
RU2793922C2

RU 2 787 157 C2

Authors

Kuk, Majkl

Kasibkhatla, Skhajladzha

Miller, Endryu T.

U, Tom Yao-Khsiang

Dates

2022-12-29Published

2018-05-17Filed